Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss CNBC

Pfizer on Monday said it will seek regulatory approval for a Lyme disease vaccine candidate despite the shot failing a late-stage trial. Pfizer said the vaccine missed the trial’s statistical goal … [+2690 chars]Read More